Stocks and Investing Stocks and Investing
Mon, April 4, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (CARR) at Buy with Decreased Target to $60 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (ALLE) at Buy with Decreased Target to $150 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Bhavan Suri Downgraded (BLND) to Hold on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $8 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Bonnie Herzog Maintained (ZVIA) at Strong Buy with Decreased Target to $16 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (ZLAB) at Buy with Decreased Target to $112 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Nash Maintained (ZION) at Hold with Increased Target to $78 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Paul Coster Upgraded (ZBRA) to Buy and Decreased Target to $500 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (ALGT) at Buy with Decreased Target to $267 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Whit Mayo Initiated (ALHC) at Buy and Held Target at $19 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Sean Steuart Downgraded (BEP) to Hold on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (APLS) at Buy with Increased Target to $69 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Suneet Kamath Maintained (AMP) at Strong Buy with Increased Target to $350 on, Apr 4th, 2022
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (APA) at Buy with Increased Target to $45 on, Apr 4th, 2022
Sun, April 3, 2022
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (AMZN) at Buy on, Apr 3rd, 2022
Fri, April 1, 2022
[ 12:00 AM ] - WOPRAI
Lawrence Biegelsen Maintained (BDX) at Hold with Increased Target to $285 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Ben Pham Maintained (BEP) at Buy with Increased Target to $42 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Downgraded (ZBH) to Hold and Increased Target to $129 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $50 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Ronald Kamdem Initiated (ADC) at Buy and Held Target at $75 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Adrienne Yih Downgraded (AEO) to Hold and Decreased Target to $19 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Chris Shibutani Downgraded (AMLX) to Hold and Decreased Target to $10 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (APTV) at Sell with Decreased Target to $108 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Josh Beck Maintained (BLND) at Buy with Decreased Target to $6 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Downgraded (BLND) to Hold and Decreased Target to $5.5 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Downgraded (BLND) to Hold and Held Target at $5 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Joseph Vafi Downgraded (BLND) to Hold and Decreased Target to $5 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Terry Tillman Maintained (BLND) at Hold with Decreased Target to $5.5 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Downgraded (BKU) to Hold and Held Target at $50 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022

Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022


Published on 2024-10-27 20:16:38 - WOPRAI, Emmanuel Papadakis
  Print publication without navigation


Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $200 on, Apr 1st, 2022.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $217 on, Tuesday, February 1st, 2022


This is the rating of the analyst that currently disagrees with Emmanuel

  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $339 on, Wednesday, February 23rd, 2022
Contributing Sources